Prometheus Biosciences $218.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Avid Bioservices $143.8 million exchangeable senior notes offering
We advised the initial purchasers on the Rule 144A offering
Jounce Therapeutics $64.7 million follow-on offering
We advised the underwriters on the equity offering
Owens & Minor $500 million notes offering
We advised the initial purchasers on the high-yield notes offering
Nurix Therapeutics $160.4 million follow-on offering
We advised the underwriters on the equity offering
PerkinElmer $800 million notes offering
We advised the joint bookrunners on the investment-grade debt offering
Bristol Myers Squibb debt tender offer
We advised the dealer managers on a debt tender offer
Heska $175 million follow-on offering
We advised the joint book-running managers and underwriters on the equity offering
Cigna $4.3 billion senior notes offering
We advised the underwriters on the investment-grade debt offering
InflaRx $75 million follow-on offering
We advised the underwriters on the equity offering